Which treatment is NOT used in acute angle closure glaucoma?

In the context of treating acute angle closure glaucoma, mydriatic agents are not used because they can worsen the condition. Acute angle closure glaucoma occurs when the iris is pushed forward, blocking the drainage angle of the eye and leading to a rapid increase in intraocular pressure. Mydriatic agents dilate the pupil, which can further constrict the already compromised drainage angle, increasing pressure and potentially leading to more severe complications.

In contrast, carbonic anhydrase inhibitors, mannitol, and topical beta blockers are effective in managing this condition. Carbonic anhydrase inhibitors reduce the production of aqueous humor, lowering intraocular pressure. Mannitol, an osmotic agent, helps draw fluid out of the eye and reduces pressure. Topical beta blockers decrease aqueous humor production, contributing to pressure reduction as well. Thus, these treatments are appropriate for the management of acute angle closure glaucoma, while mydriatic agents pose a risk and are avoided.